Skopos Labs, Inc. Amgen Inc Transaction History
Skopos Labs, Inc.
- $225 Million
- Q2 2024
A detailed history of Skopos Labs, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Skopos Labs, Inc. holds 3,339 shares of AMGN stock, worth $1.07 Million. This represents 0.46% of its overall portfolio holdings.
Number of Shares
3,339
Previous 3,339
-0.0%
Holding current value
$1.07 Million
Previous $945 Million
99.89%
% of portfolio
0.46%
Previous 0.41%
Shares
2 transactions
Others Institutions Holding AMGN
# of Institutions
3,082Shares Held
417MCall Options Held
7.24MPut Options Held
6.26M-
Vanguard Group Inc Valley Forge, PA51.9MShares$16.7 Billion0.32% of portfolio
-
Black Rock Inc. New York, NY46MShares$14.8 Billion0.33% of portfolio
-
State Street Corp Boston, MA29MShares$9.33 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA14.4MShares$4.65 Billion3.32% of portfolio
-
Morgan Stanley New York, NY14.4MShares$4.62 Billion0.35% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $172B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...